Delivery Order SPE2DB20D1100-SPE2DB24FB6X2

Award Date 5/8/24
Potential Completion Date 5/9/24
Potential Value $2.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $1,524.36, is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 150ML, a pharmaceutical product. This delivery order is placed under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp,...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $3,206.66 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 180ML pharmaceutical products. The contract has an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $1,657.99 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564197864 - QUILLIVANT XR 25 MG/5 ML SUSP 120ML. This order was placed under Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and effective through December 31, 2025. The IDC serves as the primary vehicle for...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $6,457.75 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The delivery order is for QUILLIVANT XR ORAL SUSP 60ML 5MG/ML, a specialty pharmaceutical product, with a completion date of February 16, 2024. This award is part of an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,051.36 firm fixed-price delivery order is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 60ML, a specialty medication. The contract has an ultimate completion date of December 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,505.64 firm fixed-price delivery order is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 120ML, a medication. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order valued at $1,812.45 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The order is for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,298.59 Firm Fixed Price Delivery Order contract is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 180ML, a prescription medication. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as...
The Defense Logistics Agency (DLA) awarded a $3,188.50 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 180 ml of Quillivant XR 25 mg/5 ml suspension. This order is part of Amerisourcebergen's $999,999,999.00 indefinite delivery contract with DLA to deliver a comprehensive range of medications and medical supplies to support the Department of Defense's military treatment programs and facilities worldwide. The delivery...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, to provide QUILLIVANT XR 25 MG/5 ML SUSP 180ML. This $1,477.21 contract has a completion date of February 15, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and no set-aside designation was used. The contract is part of a larger...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FB6X2
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $2,060.52 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 180ML prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, through which the company provides a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 8/7/24, 10:17 AM